MAG3 scan
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
A MAG3 scan is a diagnostic imaging procedure that allows a nuclear medicine technologist to visualize the kidneys and learn more about how they are functioning. MAG3 is an acronym for Mercapto Acetyl Tri Glycine, a compound that is chelated with a radioactive element - Technetium-99m.
Scan procedure
After injection into the venous system, the compound is excreted by the kidneys and its progress through the renal system can be tracked with a gamma camera. If the kidney is not getting blood for example, it will not be viewed at all, even it looks structurally normal in medical ultrasonography or magnetic resonance imaging. If the kidney is getting blood, but there is an obstruction lower down, the contrast will not pass beyond the level of the obstruction, whereas if there is a partial obstruction then there is a delayed transit time for the MAG3 to pass.[1] More information can be gathered by calculating time activity curves; with normal kidney perfusion, peak activity should be observed after 3-5 minutes. The relative quantitative information gives the differential fuction between each kidney's filtration activity.
Clinical use
The technique is very useful in evaluating the functioning of kidneys. It is widely used before renal transplantation to assess the vascularity of the kidney to be transplanted and with a test dose of captopril to highlight possible renal artery stenosis in the donor's other kidney,[1] and later the performance of the transplant.[1][1]
The use of the test to identify reduced renal function after test doses of captopril (an angiotensin converting enzyme inhibitor drug) has also been used to identify the cause of hypertension in patients with renal failure.[1][1] Initially there was uncertainty as to the usefulness,[1] or best test parameter to identify renal artery stenosis, the eventual consensus was that the distinctive finding is of alteration in the differential function.[1]
History
It was developed in 1986,[1] first trialled clinically the following year,[1] and passed phase III testing in 1988.[1]
99mTc-MAG3 has replaced the older Iodine-131 orthoiodohippurate or I131-Hippuran because of better quality imaging regardless of the level of renal function,[1] and with the benefit of being able to administer lower radiation dosages.[1]
Footnotes
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
